AI assistant
Sending…
EyePoint Pharmaceuticals, Inc. — Director's Dealing 2010
Dec 10, 2010
32254_dirs_2010-12-10_2eaf8598-ed6a-4a0a-bf13-2bee4a62a4d3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: pSivida Corp. (PSDV)
CIK: 0001314102
Period of Report: 2010-12-09
Reporting Person: Ashton Paul (Director, President and CEO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-12-09 | Employee Stock Option (right to buy) | $3.45 | A | 87380 | Acquired | 2020-07-22 | Common Stock (87380) | Direct |
Footnotes
F1: The option becomes exercisable in four equal annual installments beginning on July 22, 2011.
More from EyePoint Pharmaceuticals, Inc.
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 6
Investor Presentation
2026
Apr 13
Director's Dealing
2026
Mar 24
Legal Proceedings Report
2026
Mar 20
Regulatory Filings
2026
Mar 4
Regulatory Filings
2026
Mar 2
Director's Dealing
2026
Feb 18
Major Shareholding Notification
2026
Feb 12
Director's Dealing
2026
Jan 7